RE: Whilst its quiet ? ! . . . .5 Mar 2025 13:43
Whilst yes, we all await trial data and positive fingers crossed, early trial data to date has only reduce the value of the company, along with more dilution. Hopefully good trial data this time, will be accompanied with news of partnership with big pharma or indeed a sale. Otherwise we will be walking into 2026 cap in hand. Gla